Objective The Hospital Anxiety and Depression Scale (HADS) is a widely used screening measure of anxiety and depression symptoms. However, prior analyses of the measure have found heterogeneous factor structures and called into question its ability to differentiate between symptoms of anxiety and depression. As part of efforts to implement mental health screening in cystic fibrosis (CF) care, the European Cystic Fibrosis Society (ECFS) and Cystic Fibrosis Foundation (CFF) conducted an international survey of 1,454 CF professionals. The HADS was the most commonly used measure in Europe and third most across all 48 countries surveyed. However, the HADS has not been validated for CF. Thus, the objective of this study was to examine its factor structure in a sample of adolescents and young adults with CF. Methods Three theory-based models were tested in 727 individuals with CF (ages 12-25 years, 54% female) using confirmatory factor analyses, with an additional two models tested to improve model fit. Results Chi-square difference tests and majority of fit indices indicated a three-factor structure based on Clark and Watson's tripartite model best fit the data. Conclusions The original HADS two-factor structure demonstrated problematic fit in this sample, indicating poor discrimination between symptoms of anxiety and depression. A threefactor structure demonstrated best fit, indicating existing scoring guidelines and cutoffs would be inappropriate for use with this patient population. Use of the HADS to screen for anxiety and depression in CF could lead to an underestimation of clinically relevant symptomatology for depression and potential overestimation of anxiety symptoms.
varying by country, median life expectancy for an individual born with CF in 2015 is $45 years of age (Cystic Fibrosis Foundation, 2016) .
Individuals living with CF are at risk for developing symptoms of anxiety and depression (Quittner et al., 2014) . Notably because of the rapidly increasing life expectancy, this risk has been reported to increase with age (Quittner et al., 2014) . Additionally, symptoms of anxiety and depression have been associated with worse health outcomes and health-related quality of life, including worse physical and social functioning, and interpersonal relationships in individuals with CF (Riekert, Bartlett, Boyle, Krishnan, & Rand, 2007; Yohannes, Willgoss, Fatoye, Dip, & Webb, 2012) . Depressive symptoms have also been associated with more hospitalizations (Snell, Fernandes, Bujoreanu, & Garcia, 2014) , worse pulmonary function (Riekert et al., 2007) , and poorer rates of adherence (Smith et al., 2010; Hilliard, Eakin, Borrelli, Green, & Riekert, 2015) . Therefore, regular screening of these psychological symptoms is critical for identifying and treating these symptoms, and thus for improving daily functioning and health outcomes.
The International Depression and Anxiety Epidemiological Study (TIDES) measured rates of anxiety and depression symptoms in 6,088 individuals with CF across nine countries using the Hospital Anxiety and Depression Scale (HADS) and the Center for Epidemiological Studies-Depression scale (CES-D) in five of the nine countries (Quittner et al., 2014) . Elevated rates of anxiety were reported by 22% of adolescents and 32% of adults. However, the rates of elevated symptoms of depression varied depending on the measure: 5% of adolescents and 13% of adults reported elevations on the HADS, compared with 19% of adolescents and 29% of adults with the CES-D.
Results of the TIDES study led to the development of an international guidelines committee sponsored by the European Cystic Fibrosis Society (ECFS) and Cystic Fibrosis Foundation (CFF). These guidelines recommended the use of two widely used and wellvalidated, free measures of anxiety and depression symptoms: Generalized Anxiety Disorder 7 (GAD-7) Scale and the Patient Health Questionnaire-9 (PHQ-9; Quittner et al., 2016) . Notably, an international study of 1,454 CF professionals conducted by ECFS and CFF reported that the HADS was one of the three most frequently used measures for mental health screening across 48 countries and the most commonly used measure in Europe . Unfortunately, the HADS has not been validated in CF and the factor structure and psychometrics should be evaluated in this population before using it for clinical decision making. Many of the existing studies examining the HADS factor structure have used community samples. The other most commonly used populations include cancer, cardiovascular disease, and traumatic brain injury (see Table I ). The symptom presentation for individuals with CF can be highly complex because of the number of organ systems involved, leading to a unique treatment regimen, and variability in the type of complications, which makes comparisons with other chronic illness populations difficult. Additionally, to the best of our knowledge, no prior studies have tested the factor structure of the English version of the HADS in adolescents. Therefore, further examination of the HADS is warranted to determine whether it is appropriate for use in CF.
The HADS is composed of two scales, with seven items each for anxiety and depression symptoms. The items were developed by the authors based on "psychic symptoms of neurosis," including anhedonia and "psychic manifestations of anxiety neurosis" and were not developed to map onto DSM criteria (Zigmond & Snaith, 1983, p. 362) . Additionally, the items were developed for use with individuals with physical illnesses based on the exclusion of items measuring the physical symptoms of depression (e.g., appetite changes, fatigue) that may be attributable to the physical illness itself.
The HADS also differs from other self-report measures of depression in its focus on anhedonia (five of seven items), defined as "lack of enjoyment from, engagement in, or energy for life's experiences; deficits in the capacity to feel pleasure or take interest in things" (American Psychiatric Association, 2013, p. 817) . The exclusion of somatic items has led to its widespread use for measuring anxiety and depression in individuals with a range of chronic conditions, including cancer, cardiac disease, and chronic fatigue syndrome (Johnston, Pollard & Hennessey, 2000; Martin, Lewin, & Thompson, 2003; McCue, Buchanan, & Martin, 2006) . However, there is limited evidence that somatic symptoms in individuals with chronic health conditions are less valid indicators of depression (Simon & Von Korff, 2006) . Additionally, examination of item endorsement in TIDES indicated that somatic symptoms on the CES-D were not the most frequently endorsed (Quittner, Barker, Goldbeck, Duff, & Abbott, 2015) .
In addition to its wide-spread use in clinical care, the HADS is also frequently used in research, primarily with chronic illness populations. Notably, Zigmond and Snaith's original HADS development paper (Zigmond and Snaith, 1983) has over 18,000 citations, 86% of which are in medical journals (Elsevier Science Publishers, 2017) . In CF research, the HADS has been recently used to predict health-related quality of life (Olveira et al., 2016) , distress while undergoing evaluation for lung transplantation (Søyseth et al., 2016) , and physical activity and fatigue (Orava et al., 2017) . Additionally, scores on the HADS have also been associated with changes in lung function (Backströ m-Eriksson, Bergsten-Brucefors, Hjelte, Melin, & Sorjonen, 2017) and with barriers in transitioning to adult care (Askew et al, 2017) . Although the HADS is commonly used with adolescents and adults with CF for both clinical care and research, its factor structure and psychometric properties have not been tested in the CF population. Thus, the purpose of this study was to evaluate the factor structure and psychometric properties of the HADS in a sample of adolescents and young adults with CF.
Prior Studies on the HADS Factor Structure
Studies examining the HADS factor structure in other illness groups have had highly variable results. A systematic review by Cosco and colleagues (Cosco et al., 2012) identified 50 studies of the HADS (in any language) published between 2000 and 2010 that used principal component analysis (PCA), exploratory factor analysis (EFA), or confirmatory factor analysis (CFA) to examine its factor structure. Of these studies, only half supported a two-factor structure, most commonly the anxiety and depression scales proposed by the developers of the HADS, Zigmond and Snaith (1983) . Seventeen studies found a three-factor structure and several others reported either a unidimensional or four-factor structure. A pattern emerged between the analytic methods used and the resulting factor structures: PCA and EFA primarily resulted in two-factor structures, while CFA revealed primarily three-factor structure models fit best. Importantly, a majority of the studies did not account for the categorical item responses for the HADS and conducted analyses designed for continuous data, therefore limiting the validity of their results.
Because of the existent research on the HADS factor structure, confirmatory analysis to test a priori models based on theory may be more appropriate. In addition to the original two-factor structure, the model most commonly reported is based on Clark and Watson's (1991) tripartite theory, which poses that underlying anxiety and depression are (1) high negative affect, (2) low positive affect (or anhedonia), and (3) autonomic anxiety. The tripartite model was first tested in the HADS using CFA in a sample of 2,547 adults by Dunbar and colleagues (Dunbar et al., 2000) and was found to best fit the HADS as both a simple and a hierarchical three-factor structure. Since that publication, Clark and Watson's tripartite model has been reported as the best fitting model for the English version of the HADS in nine studies using CFA. Tripartite model: F1: 3, 9, 13; F2: 1, 5, 7, 11; F3: 2, 4, 6, 8, 10, 12, 14; Friedman model: F1: 3, 5, 9, 13; F2: 1, 7, 11; F3: 2, 4, 6, 8, 10, 12, 14; Skilbeck model: F1: 3, 5, 9, 13; F2: 1, 7, 11, 6, 8, 14; F3: 2, 4, 10, 12. Additionally, of all studies using CFA for factor analysis in medical samples, the majority reported a threefactor structure (12 of 18; see Table I ).
Given the inconsistent findings, the utility of the HADS as a screening measure of anxiety and depressive symptoms has been called into serious question. Prior authors have concluded that the HADS does not accurately discriminate between these symptoms in other populations and may be more appropriate as a dimensional measure of emotional distress, rather than a categorical measure of discriminating between anxiety and depression (Cosco et al., 2012; Norton et al., 2013) . However, the HADS continues to be used in CF research and clinical care. Therefore, understanding its psychometric properties and determining if the HADS is an appropriate measure for individuals with CF is of increased importance.
Methods

Participants
The data used in these analyses originated from the TIDES study, which recruited participants from 154 CF centers across nine countries between 2005 and 2011 (Quittner et al., 2014) . Institutional review board approval was obtained at the individual sites. Consent was obtained from individuals over 18 years of age, and from parents of participants 12-17 years of age, who also signed assent. All individuals with a confirmed diagnosis of CF completed the HADS at a routine clinic visit. Medical information was obtained from chart review. For the purposes of this analysis, we investigated the factor structure of the English version of the HADS in a sample of 727 adolescents and young adults aged 12-25 years (M ¼ 18.62, SD ¼ 3.91, 54.09% female) from the United States. Participants in our sample had mild disease severity, as defined by a spirometry measure for lung function, forced expiratory volume in one second percent predicted ( 
Measures
Hospital Anxiety and Depression Scale
The HADS item responses are on a four-point Likerttype scale (0-3), indicating the severity of each symptom over the prior week (Zigmond & Snaith, 1983) . The following severity cutoff scores for anxiety and depression have been recommended by the authors of the measure: score of 8-10 ¼ mild, 11-15 ¼ moderate, and !16 ¼ severe.
Hypothesized Factor Structure of the HADS in Patients With CF
Three theoretical factor structures were tested using CFA (see Figure 1 ). Model 1: Two correlated factors, anxiety and depression, with odd numbered items specified to load onto the anxiety factor and even numbered items specified to load onto the depression factor. This model is based on the original two-factor structure proposed by the authors of the HADS. Model 2: Consistent with Clark and Watson's (1991) tripartite theory of anxiety and depression, three correlated factors were hypothesized: negative affect (1, 5, 7, 11), anhedonia (2, 4, 6, 8, 10, 12, 14) , and autonomic anxiety (3, 9, 13). Model 3: A hierarchical three-factor structure building on the tripartite theory, with negative affect composed of its own indicators as noted above, and simultaneously functioning as a higher-order factor leading to anhedonia and autonomic anxiety.
Statistical Analyses
The psychometric properties of the HADS were evaluated using SPSS Statistics Version 24.0 (IBM, 2015) to calculate item-total correlations and reliability. MPlus Version 7.0 was used to run the CFA (Muthén & Muthén, 1998 . Although no HADS data were missing, 6 and 8% of participants had missing medical data (i.e., BMI and FEV 1 % predicted, respectively).
Evaluation of Model Fit
Owing to the ordinal nature of the Likert-type response options, a mean-and variance-adjusted weighted least square (WLSMV) estimator, which is a robust weighted least squares estimation method, was used for the CFA (Kline, 2015; Finney & DiStefano, 2013) . Because the chi-square test of exact fit tends to be highly sensitive to larger sample sizes, other fit indices, including the comparative fit index (CFI), the Tucker-Lewis Index (TLI), and the root mean square error of approximation (RMSEA) were examined. CFI and TLI values >0.95 indicate good model fit, and RMSEA values of 0.05 indicate close model fit (Brown, 2006; Hu & Bentler, 1999) . In addition, the weighted root mean square residual (WRMR) was used, with a value <1.0 indicating good fit (Yu & Muthén, 2002) . These four fit indices, CFI, TLI, RMSEA, and WRMR are less affected by sample size, compared with chi-square, and therefore, are better indicators of model fit in larger samples (Fan, Thompson, & Wang, 1999) . Following determination of model fit, the three hypothesized models were compared using a chi-square difference (v 2 D) test, computed using the MPlus DIFFTEST option (Muthén & Muthén, 1998 , as standard chisquare difference testing cannot be used in WLSMV CFA. Significant chi-square difference tests indicate that the model with more freely estimated parameters demonstrates better fit (Kline, 2015) .
Results
Anxiety and Depression
The mean score on the HADS Anxiety scale (HADS-A) was 6.13 (SD ¼ 3.74, range ¼ 0-18) and the mean score on the HADS Depression scale (HADS-D) was 2.74 (SD ¼ 2.81, range ¼ 0-15). Ms and SDs for individual items are provided in Table III . Based on established cutoff scores of 8 on the anxiety and depression scales (Zigmond & Snaith, 1983) , indicating at least mild symptomatology, 31.2% (n ¼ 227) of participants were elevated on anxiety and 7.4% (n ¼ 54) were elevated on depression.
Factor Structure As expected because of the larger sample size, all chisquare tests were significant; therefore, other fit indices were examined to determine goodness of fit (see Table III for Model Fit Statistics). The two-factor structure of anxiety and depression (Model 1) evidenced acceptable model fit based on the CFI and TLI (Table II) . However, the RMSEA and WRMR indices were not as favorable. In addition, the two factors were moderately correlated (r ¼ .68). Next, the three-factor structure posited by the tripartite theory, negative affect, anhedonia, and autonomic anxiety (Model 2) was tested. This model evidenced better fit based on the RMSEA, CFI, TLI, and WRMR (Table II) . Additionally, the chi-square difference test was significant (v 2 (2) ¼ 38.88, p < .01), indicating the three-factor model, with a higher number of free parameters, fits the data better than the two-factor model. Strong correlations were evidenced between negative affect and anhedonia (r ¼ .72), and negative affect and autonomic anxiety (r ¼ .89), suggesting a large proportion of shared variance between these latent variables. The correlation between anhedonia and autonomic anxiety was moderate (r ¼ .57).
Next, for Model 3, directed paths from negative affect to anhedonia and autonomic anxiety were added to create a hierarchical factor. Results indicated this model had comparable fit with Model 2 across all indices (Table II) . Additionally, the chi-square difference test indicated that Model 3 fits the data significantly better than Model 1 (v 2 (1) ¼ 38.94, p < .01). Therefore, results indicated that both three-factor models had a better fit for this sample than the two- factor model. Finally, individual item loadings were explored for each model by examining item standardized estimates, all of which evidenced moderate to strong associations with their given latent variable (Table III) .
Reliability
Reliability of the original scales of the two-factor measure (Model 1) was acceptable: HADS-A scale (Cronbach's a ¼ 0.82) and HADS-D scale (a ¼ 0.75). The corrected item-total correlations for each item on the HADS-A ranged from .45 to .66. The item-total correlations for each item of the HADS-D ranged from .31 to .64, with Items 14 (.31; "I can enjoy a good book or radio or TV program") and 8 (.38, "I feel as if I am slowed down") contributing the least to the total observed score. Reliability of the three-factor measure (Model 3) was also acceptable: autonomic anxiety (a ¼ 0.71), item-total correlations ranged from .46 to .58; negative affect (a ¼ 0.72), item-to-total correlations ranged from .43 to .56; and anhedonia (a ¼ 0.75), item-total correlations ranged from .31 to .64. Because anhedonia and the HADS-D scale share the same items, Items 14 and 8 again had the lowest item-total correlation with the scale, suggesting these items have limited utility. Item 14 was positively skewed, with most participants endorsing that they could "often" enjoy a good book or radio or TV program.
Post Hoc Analyses: Modifications to Three-Factor Model Next, modifications were conducted to improve model fit for the three-factor models. Modification indices suggested fit would be most improved by correlating Items 7 ("I can sit at ease and feel relaxed") and 8 ("I feel as if I am slowed down") with anhedonia and negative affect, respectively (estimated v 2 $58-85). Additionally, the majority of anomalous loadings reported in prior studies involved either Item 7 (20 studies) and/or Item 8 (12 studies; Cosco et al., 2012) . Specifically, these items tended to have factor loadings >0.40 on a different factor than intended. Therefore, Model 3 was reanalyzed with the addition of these two cross-loadings, creating Model 4. Model 3 was then modified an additional time, by removing Items 7 and 8 altogether, creating Model 5 (Table II) .
Model 4 demonstrated improved fit across all indices, but Model 5 showed further improvement in fit across all indices. Therefore, Model 5, a hierarchical three-factor model without Items 7 and 8, was the best model for these data (v 2 (52) ¼ 62.84, p ¼ .14; CFI ¼ 0.998; TLI ¼ 0.997; RMSEA ¼ 0.017; WRMR ¼ 0.61).
Measurement Invariance
To test whether our final model was consistent across age and gender, we conducted multiple measurement invariance tests. As a first step to test for measurement invariance, the best fitting model (Model 5) was individually tested by each group (i.e., male, female, teen, adult). All four tests demonstrated good fit across all indices (see Table II ). Next, increasingly constrained models (configural, scalar, factor mean invariance) were tested and compared using the following fit indices: v 2 , RMSEA, CFI, TLI, and WRMR. A change of À0.010 for CFI, or of !0.015 for RMSEA was interpreted to indicate a worsening of model fit and lack of invariance between the groups (Chen, 2007) . Results showed no evidence of configural or scalar invariance (see Table II) , suggesting the measurement model works similarly across age and gender and group differences among latent factors reflect "true" differences in each construct and are not a measurement artifact. Consistent with expectations of higher rates of depression in females versus males and increasing rates of depression across adolescents into young adulthood, negative affect was 0.38 SDs higher for females compared with males, and 0.31 SDs higher for young adults compared with adolescents.
Discussion
The current study examined the psychometric properties and factor structure of the HADS in a sample of adolescents and young adults with CF. The HADS evidenced good reliability, most items demonstrated good item-total correlations and factor loadings, and the correlation between the anxiety and depression scales in the two-factor model was consistent with prior research (Dunbar et al., 2000) . Three hypothesized models were tested and compared. Consistent with prior studies, the latent factor in the three-factor models were labeled negative affect, anhedonia, and autonomic anxiety, with negative affect acting as a hierarchical factor leading to anhedonia and autonomic anxiety in Models 3 and 5 (Dunbar et al., 2000) . Results indicated that this three-factor structure based on Clark and Watson's tripartite theory (Clark and Watson, 1991) provided the best fit for the data, with both three-factor models demonstrating better fit to the data than the original two-factor structure of anxiety and depression. These results are consistent with several factor analytic studies in other chronic conditions (Table I) . Two post hoc models were tested. The first included cross-loadings for Items 7 and 8, which improved model fit. Next, the second post hoc model removed Items 7 and 8, and dramatically improved model fit, suggesting that not only do these not adequately discriminate between symptoms of anxiety and depression but their inclusion hindered model fit.
In addition to issues with the factor structure, the original depression scale of the HADS has several flaws that limit its utility as a screener for symptoms of depression. Specifically, prior research has shown that the HADS-Depression scale focuses almost entirely on anhedonia, and excludes somatic symptoms and other important factors (e.g., feelings of worthlessness or guilt; difficulty concentrating, indecisiveness) currently part of the diagnostic criteria for depression (American Psychiatric Association, 2013) . As previously mentioned, the evidence that somatic symptoms in individuals with chronic health conditions are less valid indicators of depression is limited (Simon & Von Korff, 2006) , weakening the rationale for their exclusion. Further, the HADS has been reported to have poor sensitivity in identifying depression in individuals with medical conditions when compared with structured diagnostic interviews (Brennan, Worrall-Davies, McMillan, Gilbody, & House, 2010) and other self-report measures such as the PHQ-9 (Pettersson, Boströ m, Gustavsson, & Ekselius, 2015) . The HADSDepression scale's poor sensitivity and limited focus on anhedonia may result in missed cases of depression in clinical populations.
Additionally, the anxiety factor in this sample fits the data better when it was separated into two factors (autonomic anxiety and negative affect), also consistent with prior studies. While this factor structure does not preclude its use in hospital settings and with individuals with CF, it suggests that this scale may be measuring more than just anxiety. Specifically, negative affect is considered a transdiagnostic factor underlying both anxiety and depression (Barlow, SauerZavala, Carl, Bullis, & Ellard, 2014) . The inclusion of negative affect in a measurement of anxiety makes it difficult to distinguish whether the symptoms endorsed are related to anxiety and/or depression. Therefore, the anxiety scale, in combination with the anhedonia scale, should be interpreted as indicating overall levels of emotional distress, rather than a screening tool to assess anxiety and depression.
A high total score on the HADS, therefore, may indicate that the patient is experiencing significant emotional distress, and may be at-risk for developing anxiety and/or depression, given the tripartite theory of these disorders. This is an important distinction and should guide clinical use and interpretation of this measure when used with individuals with CF. Specifically, existing cutoff scores for elevations for anxiety and/or depression are most likely not appropriate for use with this patient population, and may lead to underestimations of clinically relevant symptomatology for depression and potential overestimation of anxiety. This, however, does not preclude its utility as a research tool, especially considering its prior associations with health-related quality of life (Olveira et al., 2016) , physical activity and fatigue (Orava et al., 2017) , among other outcomes. Future research should explore the utility of the HADS as a measure of constructs underlying both depression and anxiety and its correlates to other hypothesized factors (e.g., distress tolerance) in individuals with chronic illness.
A limitation of this study was the absence of a goldstandard diagnostic measure for anxiety or depression that would have allowed for analysis of sensitivity of the HADS in the CF sample. Additionally, without a diagnostic tool, cut-scores could not be calculated for the HADS in this sample. However, although the psychometric properties and factor structure of the HADS have been examined in other chronically ill adult patients, it had not been studied in a sample of adolescents and young adults with CF. Additionally, majority of prior studies did not take into account the ordinal-categorical nature of the HADS item responses, and used statistical methods designed for continuous data. To our knowledge, this is the first study to analyze the factor structure of the English language version of the HADS in adolescents.
This study analyzed the factor structure of the HADS in a large sample of adolescents and young adults with CF from across the United States. Results indicated that the original two-factor HADS does not appropriately discriminate between symptoms of anxiety and depression, and may instead be measuring a global construct of emotional distress when all items are combined or measuring constructs that underlie depression and anxiety (e.g., negative affect) in its three-factor format. These results call into question the validity and utility of this measure as a screening tool for anxiety and depression in this patient population. Additionally, existing scoring guidelines and cutoffs are inappropriate for use with this patient population and could lead to inaccurate estimations of symptom elevations. Therefore, these findings should be used to guide clinical use and interpretation of this measure when used with individuals with CF. For the specific purpose of screening for symptoms of depression and anxiety, it is our recommendation that clinicians follow the CFF and ECFS mental health guidelines, which recommend the use of the PHQ-9 and GAD-7 (Quittner et al., 2016) . 
